Key Announcement

Indegene Limited has been announced as the first industry partner of the Indo-UK Life Science Corridor, a partnership between the Centre for Cellular and Molecular Platforms (C-CAMP) and Imperial College London.

Partnership Details

The Indo-UK Life Science Corridor is supported through the Imperial Global India initiative and connects world-class research in India and the UK with entrepreneurship, industry expertise, and pathways to translation. The corridor enables formal, two-way sharing of knowledge and evidence on priority challenges, innovation readiness, and ecosystem needs.

As part of the collaboration, Indegene, C-CAMP, and Imperial College London will:

  • Co-develop entrepreneurship programs
  • Support the exchange of knowledge and talent between India and UK
  • Help define industry challenges
  • Support startup exchanges and ecosystem immersion programs

Initial Focus Areas

The partnership will initially focus on:

  • Antimicrobial resistance
  • Diagnostics
  • Digital health
  • Agritech
  • Brain science
  • Mental health

Event Context

The announcement was made at the C-CAMP–Imperial joint Roundtable on International Partnerships for AI Discovery and Innovation, convened under the Government of Karnataka's Global Innovation Alliance initiative as part of the Bengaluru Tech Summit 2026.

Executive Commentary

Dr. Taslimarif Saiyed, CEO, C-CAMP: "Global health challenges cannot be solved in isolation. This understanding was central to our vision for the Indo-UK Life Science Corridor, which connects the complementary innovation ecosystems of Imperial College London and C-CAMP to enable crossborder problem-solving."

Amanda Wolthuizen, Vice-President (Strategy), Imperial College London: "Welcoming Indegene as the first industry partner is an important moment for this partnership. Indegene's expertise in life sciences make them an ideal first partner as we strengthen India-UK links and grow our network of industry collaborators."

Dr. Saurabh Jain, Vice President - Global Delivery Centers, CSR, and Advocacy, Indegene: "The next decade of life sciences innovation will be defined by how well we connect science, talent, and industry across borders. This Corridor brings together the strengths of India and the UK, giving promising ideas a clearer path from discovery to real-world impact."

Company Background

Indegene Limited is described as the AI-native operating partner for modern life sciences, bringing deep industry context to the Corridor, with a track record of working with the world's top 20 biopharma companies. The company orchestrates commercial, medical, R&D, and safety operations across the product lifecycle.

C-CAMP Background Information

C-CAMP has funded, incubated, and helped advance more than 700 startups that have raised over $720 million with cumulative valuation of approximately $2.7 billion. They have enabled completion of more than 6,000 research projects, trained over 2,200 scientific personnel, supported 420 life sciences products in the market, 1,000 patents filed, and over 300 publications.

Imperial Global India Background

Imperial College London launched Imperial Global India in 2025 to drive high-impact science and technology programs with academic, industrial, and innovation partners, nurture two-way flow of STEMB talent between UK and India, and support Imperial's growing Indian alumni network.